Healthcare provider profile · identity verified

Timothy James Joos, MD

General Practice · SEATTLE, WA · NPI 1740265735

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	398	131
Losartan Potassium	Losartan Potassium	261	74
Amlodipine Besylate	Amlodipine Besylate	238	83
Gabapentin	Gabapentin	224	56
Omeprazole	Omeprazole	216	72
Metformin Hcl Er	Metformin Hcl	200	63
Trulicity	Dulaglutide	196	29
Lisinopril	Lisinopril	152	54
Albuterol Sulfate Hfa	Albuterol Sulfate	128	34
Metoprolol Succinate	Metoprolol Succinate	120	35
Tamsulosin Hcl	Tamsulosin Hcl	109	38
Fluticasone Propionate	Fluticasone Propionate	104	43
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	17
Levothyroxine Sodium	Levothyroxine Sodium	74	26
Hydrochlorothiazide	Hydrochlorothiazide	71	28
Metformin Hcl	Metformin Hcl	70	23
Triamcinolone Acetonide	Triamcinolone Acetonide	70	37
Pantoprazole Sodium	Pantoprazole Sodium	61	19
Jardiance	Empagliflozin	60	17
Ozempic	Semaglutide	57	14
Simvastatin	Simvastatin	57	15
Bydureon Bcise	Exenatide Microspheres	56	13
Glipizide Er	Glipizide	55	21
Trazodone Hcl	Trazodone Hcl	54	16
Lovastatin	Lovastatin	53	13
Diclofenac Sodium	Diclofenac Sodium	51	21
Acetaminophen-Codeine	Acetaminophen With Codeine	48	14
Finasteride	Finasteride	47	14
Colchicine	Colchicine	41	12
Farxiga	Dapagliflozin Propanediol	41	13
Sertraline Hcl	Sertraline Hcl	41	12
Rosuvastatin Calcium	Rosuvastatin Calcium	40	13
Potassium Chloride	Potassium Chloride	39	15
Furosemide	Furosemide	38	16
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Mirtazapine	Mirtazapine	35	16
Famotidine	Famotidine	34	11
Ibuprofen	Ibuprofen	34	19
Pioglitazone Hcl	Pioglitazone Hcl	33	13
Pravastatin Sodium	Pravastatin Sodium	33	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	suppressed
Eliquis	Apixaban	29	11
Lidocaine	Lidocaine	29	suppressed
Naproxen	Naproxen	28	suppressed
Baclofen	Baclofen	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Ketoconazole	Ketoconazole	27	suppressed
Clotrimazole	Clotrimazole	26	15
Hydrocortisone	Hydrocortisone	26	11
Topiramate	Topiramate	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Allopurinol	Allopurinol	21	suppressed
Azithromycin	Azithromycin	21	18
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Meclizine Hcl	Meclizine Hcl	20	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Carvedilol	Carvedilol	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Prednisone	Prednisone	18	12
Spironolactone	Spironolactone	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Nystatin	Nystatin	12	suppressed
Torsemide	Torsemide	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Unifine Pentips	Pen Needle, Diabetic	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error